195 related articles for article (PubMed ID: 7992074)
1. Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts SW; Reubi JC; Krenning EP
Semin Oncol; 1994 Oct; 21(5 Suppl 13):1-5. PubMed ID: 7992074
[No Abstract] [Full Text] [Related]
2. Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Krenning EP; Kwekkeboom DJ; de Jong M; Visser TJ; Reubi JC; Bakker WH; Kooij PP; Lamberts SW
Semin Oncol; 1994 Oct; 21(5 Suppl 13):6-14. PubMed ID: 7992084
[No Abstract] [Full Text] [Related]
3. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
4. Sarcoidosis in a clinically unaffected joint demonstrated by somatostatin receptor scintigraphy.
Kroot EJ; Dolhain RJ; van Hagen PM; Kwekkeboom DJ
Clin Nucl Med; 2006 Aug; 31(8):501-3. PubMed ID: 16855445
[No Abstract] [Full Text] [Related]
5. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
Ahlman H; Tisell LE; Wängberg B; Nilsson O; Forssell-Aronsson E; Fjälling M
Semin Oncol; 1994 Oct; 21(5 Suppl 13):21-8. PubMed ID: 7992076
[No Abstract] [Full Text] [Related]
6. Somatostatin receptor scintigraphy (SRS): a new diagnostic tool in neuroblastoma (NB)?
Dörr U; Sautter-Bihl ML; Schilling FH; Koscielniak E; Treuner J; Bihl H
Prog Clin Biol Res; 1994; 385():355-61. PubMed ID: 7972231
[No Abstract] [Full Text] [Related]
7. Receptors on tumors studied with radionuclide scintigraphy.
Larson S
J Nucl Med; 1991 Jun; 32(6):1189-91. PubMed ID: 1646303
[No Abstract] [Full Text] [Related]
8. Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
Breeman WA; van Hagen PM; Kwekkeboom DJ; Visser TJ; Krenning EP
Eur J Nucl Med; 1998 Feb; 25(2):182-6. PubMed ID: 9473268
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
[TBL] [Abstract][Full Text] [Related]
10. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Pauwels S; Leners N; Fiasse R; Jamar F
Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
[No Abstract] [Full Text] [Related]
11. Somatostatin-receptor scintigraphy in Graves' orbitopathy.
Postema PT; Kwekkeboom DJ; van Hagen PM; Krenning EP
Eur J Nucl Med; 1996 Jun; 23(6):615-7. PubMed ID: 8662098
[No Abstract] [Full Text] [Related]
12. OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat.
Bruns C; Stolz B; Albert R; Marbach P; Pless J
Horm Metab Res Suppl; 1993; 27():5-11. PubMed ID: 8392488
[TBL] [Abstract][Full Text] [Related]
13. Indium 111 octreotide scintigraphy in angiofibroma.
Guneri EA; Degirmenci B; Durak H; Ikiz AO; Derebek E; Sutay S
Otolaryngol Head Neck Surg; 1998 Jan; 118(1):137-9. PubMed ID: 9450844
[No Abstract] [Full Text] [Related]
14. Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
Sautter-Bihl ML; Dörr U; Schilling F; Treuner J; Bihl H
Semin Oncol; 1994 Oct; 21(5 Suppl 13):38-41. PubMed ID: 7992079
[No Abstract] [Full Text] [Related]
15. Effect of chemotherapy on somatostatin receptor detection with octreotide scintigraphy in hormone-refractory prostate cancer patients.
Mencobonii M; Tredici S; Rebella L; Bergaglio M; Galbusera V; Manzara A; Claudiani F; Malcangi B; Varaldo M
Anticancer Res; 2006; 26(3B):2233-5. PubMed ID: 16821593
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
Krenning EP; Kwekkeboom DJ; Bakker WH; Breeman WA; Kooij PP; Oei HY; van Hagen M; Postema PT; de Jong M; Reubi JC
Eur J Nucl Med; 1993 Aug; 20(8):716-31. PubMed ID: 8404961
[TBL] [Abstract][Full Text] [Related]
17. What is a false-positive somatostatin receptor scintigraphy?
Reubi JC
J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170
[No Abstract] [Full Text] [Related]
18. Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
Colao A; Pivonello R; Lastoria S; Faggiano A; Ferone D; Lombardi G; Fenzi G
Eur J Endocrinol; 2000 Oct; 143 Suppl 1():S35-42. PubMed ID: 11068938
[No Abstract] [Full Text] [Related]
19. Somatostatin receptor imaging.
Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2002 Apr; 32(2):84-91. PubMed ID: 11965603
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor scintigraphy in non-medullary thyroid cancer.
Postema PT; De Herder WW; Reubi JC; Oei HY; Kwekkeboom DJ; Bruining HJ; Bonjer J; van Toor H; Hennemann G; Krenning EP
Digestion; 1996; 57 Suppl 1():36-7. PubMed ID: 8813465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
